🔎 Trials Near Me

Home › Juvenile Myelomonocytic Leukemia › California

Juvenile Myelomonocytic Leukemia clinical trials in California

3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in California.

Cities in California

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

  • Children's Hospital Los Angeles, Los Angeles
  • University of California San Francisco, San Francisco
RecruitingPhase 1/2
1 Month – 21 Years · All sexes · Updated Sep 4, 2026 · NCT05849662

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
RecruitingPhase 1
Ages 1 to 18 · All sexes · Updated Aug 25, 2026 · NCT06247787

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • and 8 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.